jcm-logo

Journal Browser

Journal Browser

Advances in Anterior Segment Surgery: Second Edition

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".

Deadline for manuscript submissions: 25 December 2025 | Viewed by 841

Special Issue Editor


E-Mail Website
Guest Editor
Sussex Eye Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, UK
Interests: laser refractive surgery; refractive lens exchange; complex cataract surgeries; vision correction surgeries; corneal transplants; keratoconus management
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

It is my pleasure to invite you to contribute to the Special Issue entitled “Advances in Anterior Segment Surgery: 2nd Edition”. This is one new volume; we published five papers in the first volume. For more details, please visit: https://www.mdpi.com/journal/jcm/special_issues/DHTHDD997W.

The aim of this Special Issue is to highlight the current themes in modern laser-, corneal-, and lens-based refractive surgery. This issue will feature three articles from world-renowned refractive surgeons on the latest trends and themes relating to refractive surgery.

We will be delighted if you are able to submit a full-length article or review on a topic of your choice in refractive, corneal, and cataract surgery. The possible areas of interest for this issue are lenticule-based surgery, surface ablations, blended vision treatments with laser refractive surgery, corneal inlay procedures, presbyopia management with monovision laser vision correction, refractive lens exchange, premium presbyopia-correcting intraocular lenses, refractive solutions for keratoconics, complex cataract surgery, biometry, cataract surgery outcomes, modern lamellar corneal transplants, etc.

We will be grateful if you can let us know whether this is something you are interested in contributing to.

Dr. Mayank A. Nanavaty
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lenticule-based surgery
  • surface ablations
  • blended vision treatments with laser refractive surgery
  • corneal inlay procedures
  • presbyopia management with monovision laser vision correction
  • refractive lens exchange
  • premium presbyopia-correcting intraocular lens
  • refractive solutions for keratoconics
  • cataract surgery
  • corneal transplant
  • biometry

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Related Special Issue

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

7 pages, 202 KiB  
Article
Morphological Features in Eyes with Prominent Corneal Endothelial Cell Loss Associated with Primary Angle-Closure Disease
by Yumi Kusumi, Masashi Yamamoto, Masaki Fukui and Masakazu Yamada
J. Clin. Med. 2025, 14(15), 5364; https://doi.org/10.3390/jcm14155364 - 29 Jul 2025
Viewed by 406
Abstract
Background: Patients with primary angle-closure disease (PACD), those with no history of acute angle-closure glaucoma or laser iridotomy, rarely present with prominent corneal endothelial cell density (CECD) loss. To identify factors associated with decreased CECD in PACD, anterior segment parameters were compared in [...] Read more.
Background: Patients with primary angle-closure disease (PACD), those with no history of acute angle-closure glaucoma or laser iridotomy, rarely present with prominent corneal endothelial cell density (CECD) loss. To identify factors associated with decreased CECD in PACD, anterior segment parameters were compared in patients with PACD and normal CECD and patients with PACD and decreased CECD, using anterior segment optical coherence tomography (AS-OCT). Patients and Methods: Ten patients with PACD and CECD of less than 1500/mm2 without a history of cataract surgery, acute angle-closure glaucoma, or prior laser glaucoma procedures were identified at the Kyorin Eye Center from January 2018 to July 2023. Patients with an obvious corneal guttata or apparent corneal edema were also excluded. Seventeen patients with PACD and normal CECD (normal CECD group) were used as the control. Simultaneous biometry of all anterior segment structures, including the cornea, anterior chamber, and iris, were assessed using a swept-source AS-OCT system. Results: Corneal curvature radius was significantly larger in the decreased CECD group compared with the corneal refractive power in the normal CECD group (p = 0.022, Mann–Whitney test). However, no significant differences were detected in other anterior segment morphology parameters. Multiple regression analysis with CECD as the dependent variable revealed that a large corneal curvature radius was a significant explanatory variable associated with corneal endothelial loss. Conclusions: Flattened corneal curvature may be a risk factor for corneal endothelial loss in patients with PACD. Full article
(This article belongs to the Special Issue Advances in Anterior Segment Surgery: Second Edition)
12 pages, 239 KiB  
Article
Ten Years’ Experience Using Proxymetacaine Hydrochloride 0.5% for Postoperative Pain Control in Epithelium-Off Corneal Crosslinking
by Mohamed Gamal Elghobaier, Issac Levy and Mayank A. Nanavaty
J. Clin. Med. 2025, 14(13), 4692; https://doi.org/10.3390/jcm14134692 - 2 Jul 2025
Viewed by 316
Abstract
Background/Objectives: To evaluate the efficacy and safety of using the preservative-free topical proxymetacaine hydrochloride (Minims, 0.5% w/v, Bausch & Lomb, UK) to control postoperative pain after epithelium-off corneal crosslinking (CXL) for keratoconus. Methods: This is an observational study [...] Read more.
Background/Objectives: To evaluate the efficacy and safety of using the preservative-free topical proxymetacaine hydrochloride (Minims, 0.5% w/v, Bausch & Lomb, UK) to control postoperative pain after epithelium-off corneal crosslinking (CXL) for keratoconus. Methods: This is an observational study of patients with mild to severe keratoconus who have undergone epithelium-off CXL. CXL was completed by applying dextran-free riboflavin (0.1%) for 10 min (Vibex Rapid; Avedro, Inc.), followed by continuous UV-A light (Avedro KXL system; Avedro, Inc.) for 30 min at an intensity of 3 mW/cm2 and an energy of 5.4 J/cm2. All patients were prescribed postoperative proxymetacaine hydrochloride PRN with an allowed frequency of up to eight times per 24 h for the first 3 days to control postoperative pain. Patients were reviewed at 1–2 weeks postoperatively for a comprehensive examination, including assessment of delayed corneal healing, removal of the bandage contact lens, and recording of subjective symptoms. Results: There were 223 eyes of 180 patients with a mean age of 24.9 ± 8.6 years (range: 13–38 years). Male patients were 72%. At their planned first postoperative visit, we found no corneal healing abnormalities, such as persistent epithelial defects, epithelial irregularities, or early postoperative stromal haze, in any patient. All patients subjectively reported that proxymetacaine drops helped them to control postoperative pain, particularly in the first 48 h. Conclusions: None of the patients reported pain after 3 days of using proxymetacaine drops up to eight times a day for the first 3 days. It appears to be a safe and effective solution to control postoperative pain without any complications. Full article
(This article belongs to the Special Issue Advances in Anterior Segment Surgery: Second Edition)
Back to TopTop